Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Fouriertransform in connection with investment in NovaCast Technologies
Mandate

Vinge advises Fouriertransform in connection with investment in NovaCast Technologies

February 04, 2010

Vinge has advised Fouriertransform, the Swedish state-owned venture capital company for the automotive industry, in its acquisition of shares through a directed new share issue in NovaCast Technologies AB (publ). NovaCast Technologies, which is listed on Nasdaq OMX Stockholm (Small Cap), develops and markets products and software intended to improve the efficiency and speed of production processes to automotive industry companies and their sub-contractors.

The investment amounts to SEK 40 million and, if approved, will make Fouriertransform the largest individual shareholder. The issue is conditional upon approval by an extraordinary shareholders’ meeting.

Vinge’s team consisted of partner Göran Nyström and associates David Andersson and Caroline Strömbäck.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025